Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

pancreatic cancer, susceptibility to, 1 - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

pancreatic cancer, susceptibility to, 1

MONDO:0011739

Also known as:PALLD familial pancreatic carcinomafamilial pancreatic carcinoma caused by mutation in PALLDpancreatic cancer, susceptibility to, type 1

Overview

Any familial pancreatic carcinoma in which the cause of the disease is a mutation in the PALLD gene.

GeneticsAutosomal dominant

Clinical Presentation

Features include: Pancreatic adenocarcinoma.

Organ System	Phenotype Count	Example Features
Digestive system	1	Pancreatic adenocarcinoma

Explore clinical features

Diagnosis

Biomarker and diagnostic research for pancreatic cancer, susceptibility to, 1 has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for pancreatic cancer, susceptibility to, 1.

217 publications have been identified in PubMed for pancreatic cancer, susceptibility to, 1. Kisho has analyzed 52 by research type. Research spans Basic Science / Preclinical (37%), Epidemiology / Natural History (29%), and Review / Meta-Analysis (25%).

Research Type	Count	% of Total
Laboratory research	19	37%

Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 7:14 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Patient Support

Financial & Access Support (External Programs)

View all programs →

Pancreatic Cancer Program

Premium/CopayClosedOperated by Good Days

Visit official site

Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.

Are you a patient organization for this condition?

Claim this page and your organization will be listed here for patients and families to find.

Be recognized as the official organization
Get notified of new trials, FDA decisions, and research
Appear in the disease page directory
Embed this content on your website — free

Medical References

External Resources

OMIM

Online Mendelian Inheritance in Man

OMIM:606856

Questions for Your Care Team

→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

pancreatic cancer, susceptibility to, 1

Overview

Clinical Presentation

Explore clinical features

Diagnosis

Research Landscape

Patient Support

Financial & Access Support (External Programs)

Are you a patient organization for this condition?

Medical References

External Resources

OMIM

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications